When combined with mutations in genes that cause hereditary breast and ovarian cancer such as BRCA1, BRCA2, PALB2 and RAD51C, depletion of Rad52 is shown to be synthetically lethal [27]. The gene discussed is RAD52; the disease is ovarian cancer.